SUPERCELL DANMARK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  10.1% 8.0% 13.0% 10.7% 7.2%  
Credit score (0-100)  24 29 17 22 34  
Credit rating  BB BB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  5,070 4,929 4,735 4,037 10,220  
EBITDA  276 277 254 210 728  
EBIT  276 277 254 210 728  
Pre-tax profit (PTP)  249.9 243.9 228.5 206.5 597.1  
Net earnings  194.8 190.1 178.1 161.1 438.2  
Pre-tax profit without non-rec. items  250 244 229 207 597  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  1,694 1,884 2,062 2,223 2,662  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,913 2,800 2,319 2,507 7,531  

Net Debt  -5,711 -2,658 -2,234 -2,090 -5,612  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,070 4,929 4,735 4,037 10,220  
Gross profit growth  19.3% -2.8% -3.9% -14.8% 153.2%  
Employees  1 1 1 1 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,913 2,800 2,319 2,507 7,531  
Balance sheet change%  114.2% -52.6% -17.2% 8.1% 200.4%  
Added value  275.9 276.8 253.6 210.0 727.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.4% 5.6% 5.4% 5.2% 7.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  6.4% 6.4% 9.9% 8.7% 14.5%  
ROI %  15.8% 15.5% 12.9% 9.8% 29.8%  
ROE %  12.2% 10.6% 9.0% 7.5% 17.9%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  28.6% 67.3% 88.9% 88.7% 35.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -2,069.8% -960.6% -881.0% -995.3% -771.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  17.2% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.4 3.1 9.0 8.8 1.5  
Current Ratio  1.4 3.1 9.0 8.8 1.5  
Cash and cash equivalent  5,711.4 2,658.5 2,234.5 2,090.5 5,612.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,693.6 1,883.7 2,061.9 2,223.1 2,661.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  276 277 254 210 364  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  276 277 254 210 364  
EBIT / employee  276 277 254 210 364  
Net earnings / employee  195 190 178 161 219